Canopy Growth (TSE:WEED – Get Free Report) had its price target boosted by equities research analysts at Bank of America from C$0.56 to C$0.65 in a report released on Friday, BayStreet.CA reports. The firm currently has an “underperform” rating on the stock. Bank of America‘s price target would indicate a potential downside of 64.48% from the company’s current price.
Other research analysts have also recently issued reports about the stock. Jefferies Financial Group decreased their target price on shares of Canopy Growth from C$0.61 to C$0.59 in a report on Wednesday, August 16th. TD Securities upped their target price on shares of Canopy Growth from C$0.70 to C$1.80 in a report on Friday. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of C$2.02.
View Our Latest Research Report on WEED
Canopy Growth Trading Up 7.6 %
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
See Also
- Five stocks we like better than Canopy Growth
- How to Read Stock Charts for Beginners
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- 3 Monster Growth Stocks to Buy Now
- MarketBeat Week in Review – 9/11 – 9/15
- What is the Shanghai Stock Exchange Composite Index?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.